Market Research

A hand holding a blue pen points at a printed page with bar graphs and line charts, illustrating data analysis. The background includes more documents on a wooden surface.

Understanding people’s perspectives regarding birth control is critical for ensuring that the development of the next generation of contraception is rooted in users’ wants and needs.

Male Contraceptive Initiative (MCI) believes that the development of the next generation of contraceptives should be driven by the needs and preferences of those who will ultimately use them. To ensure our research is user-centered, we conduct in-depth market research, collaborate with experts, and engage with diverse communities. By prioritizing user-centered design, we’re committed to developing male contraceptives that are not only effective, but also desirable for long-term use. On this page, you’ll find details about MCI’s market research activities, along with resources that demonstrate the clear demand for male contraception solutions.

MCI-supported Market Research

MCI’s International Market Research Report

To gain a deeper understanding of the global need for male contraceptives, Male Contraceptive Initiative funded a comprehensive international market research study. This study explored men’s preferences for different types of contraceptives and their willingness to use them, as well as women’s attitudes toward male contraception and their partners’ comfort levels with them taking responsibility for family planning. The findings of this groundbreaking study are available for download on our dedicated microsite.

READ THE REPORT

Table showing the top-ranking factors influencing novel male birth control choices in eight countries, listing priorities like effectiveness, STI protection, time to onset, and side effects for each country.

A world map highlights countries surveyed on male contraceptive interest. Key stats for Bangladesh, DR Congo, Côte dIvoire, Kenya, Nigeria, Vietnam, and the US are shown with data on willingness to try and potential prevalence rates.

A line graph shows cumulative interest in trying new male birth control methods within 12 months across 8 countries. The U.S., Vietnam, Nigeria, and Kenya show the highest interest, peaking at 98%, 96%, 92%, and 89% respectively.

A bar chart shows female trust in male partner birth control use across seven countries, with percentages for responses from Strongly Disagree to Strongly Agree. The U.S. is excluded. Source: malecontraceptive.org.

MCI’s Domestic Consumer Research Report

MCI conducted a comprehensive study to explore men’s experiences with existing birth control methods. By examining diverse demographics, we gained valuable insights into the unmet needs and satisfaction levels of men when it comes to contraception. Our report reveals key findings, displaying valuable insights about what men truly want from the future of contraception. Download the full report to learn how these findings inform our vision for the future of male contraception.

READ THE REPORT

External Market Research Efforts

Nguyen BT. The Demand for Male Contraception: estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data. Contraception. 2024 Mar 28:110438. doi: 10.1016/j.contraception.2024.110438. Epub ahead of print. PMID: 38555051.

Glasier A. Acceptability of contraception for men: a review. Contraception. 2010 Nov;82(5):453-6. doi: 10.1016/j.contraception.2010.03.016. Epub 2010 May 4. PMID: 20933119.

Eberhardt J, van Wersch A, Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships. J Fam Plann Reprod Health Care. 2009 Jul;35(3):161-5. doi: 10.1783/147118909788707986. PMID: 19622206.

Vouking MZ, Evina CD, Tadenfok CN. Male involvement in family planning decision making in sub-Saharan Africa- what the evidence suggests. Pan Afr Med J. 2014 Dec 3;19:349. doi: 10.11604/pamj.2014.19.349.5090. PMID: 25922638; PMCID: PMC4406389.

Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2. PMID: 24981149; PMCID: PMC4269220.

Ramos-Ortiz J, King H, DeMaria AL. Hormonal Male Contraception: Formative Research to Develop and Test Communication Messaging. Am J Mens Health. 2022 May-Jun;16(3):15579883221094702. doi: 10.1177/15579883221094702. PMID: 35748372; PMCID: PMC9240595.